Medication related osteonecrosis of the jaw
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The subjects is the patients with bisphosphonate drug or anti-RANKL monoclonal antibody drug receiving oral surgery at the Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine and the institutions of research collaboration.
Exclusion criteria
Exclusion criteria: Patients who principal investigator has determined to be inappropriate as a subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The presence or absence of MRONJ | — |
Countries
Japan
Contacts
Kobe University Graduate School of Medicine Department of Oral and Maxillofacial Surgery